PH18091A - Novel spiro-oxazolidindiones,pharmaceutical compositions containing same and method of use thereof - Google Patents

Novel spiro-oxazolidindiones,pharmaceutical compositions containing same and method of use thereof

Info

Publication number
PH18091A
PH18091A PH22931A PH22931DA PH18091A PH 18091 A PH18091 A PH 18091A PH 22931 A PH22931 A PH 22931A PH 22931D A PH22931D A PH 22931DA PH 18091 A PH18091 A PH 18091A
Authority
PH
Philippines
Prior art keywords
oxazolidindiones
pharmaceutical compositions
compositions containing
containing same
novel spiro
Prior art date
Application number
PH22931A
Other languages
English (en)
Inventor
Rodney Caughren Schnur
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PH18091A publication Critical patent/PH18091A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Photosensitive Polymer And Photoresist Processing (AREA)
  • Moulding By Coating Moulds (AREA)
  • Dental Preparations (AREA)
PH22931A 1978-08-21 1979-08-21 Novel spiro-oxazolidindiones,pharmaceutical compositions containing same and method of use thereof PH18091A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/935,199 US4200642A (en) 1978-08-21 1978-08-21 Spiro-oxazolidindiones

Publications (1)

Publication Number Publication Date
PH18091A true PH18091A (en) 1985-03-20

Family

ID=25466700

Family Applications (1)

Application Number Title Priority Date Filing Date
PH22931A PH18091A (en) 1978-08-21 1979-08-21 Novel spiro-oxazolidindiones,pharmaceutical compositions containing same and method of use thereof

Country Status (34)

Country Link
US (1) US4200642A (zh)
JP (4) JPS6011914B2 (zh)
AR (1) AR225614A1 (zh)
AT (1) AT366689B (zh)
AU (1) AU535170B2 (zh)
BE (1) BE878311A (zh)
CA (1) CA1121361A (zh)
CH (1) CH639974A5 (zh)
CS (1) CS208129B2 (zh)
DD (1) DD146602A5 (zh)
DE (2) DE2933441C2 (zh)
DK (1) DK258479A (zh)
EG (1) EG14639A (zh)
ES (1) ES483511A1 (zh)
FI (1) FI65255C (zh)
FR (3) FR2442851A1 (zh)
GB (2) GB2028318B (zh)
GR (1) GR71913B (zh)
HU (1) HU179746B (zh)
IE (1) IE48932B1 (zh)
IL (1) IL58076A (zh)
IN (1) IN152416B (zh)
IT (1) IT1123536B (zh)
LU (1) LU81613A1 (zh)
NL (1) NL7906318A (zh)
NO (1) NO792699L (zh)
NZ (1) NZ191350A (zh)
PH (1) PH18091A (zh)
PL (1) PL130686B1 (zh)
PT (1) PT70086A (zh)
SE (1) SE447116B (zh)
SU (1) SU942597A3 (zh)
YU (1) YU41488B (zh)
ZA (1) ZA794379B (zh)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4329459A (en) * 1980-05-05 1982-05-11 The Upjohn Company Tetrahydrobenzopyran derivatives
US4367234A (en) * 1980-07-28 1983-01-04 Pfizer Inc. Hypoglycemic 5-substituted oxazolidine-2,4-diones
SG56656G (en) * 1980-07-28 1987-03-27 Pfizer Hypoglycemic 5-substituted oxazolidine-2, 4-diones
ES8400116A1 (es) * 1981-10-13 1983-10-16 Pfizer "un procedimiento por analogia para la preparacion de derivados de espiro-oxindol-oxazolidindiona".
US4438272A (en) 1982-04-15 1984-03-20 Alcon Laboratories, Inc. Spiro-(fluoren-9,4'-imidazolidine)-2',5'-diones
US4540700A (en) * 1982-04-15 1985-09-10 Alcon Laboratories, Inc. Treatment of diabetic complications with certain spiro-imidazolidine-diones
US4436745A (en) 1982-04-15 1984-03-13 Alcon Laboratories, Inc. Method of inhibiting aldose reductase activity
US4464385A (en) * 1982-04-15 1984-08-07 Alcon Laboratories, Inc. Treatment of diabetic complications with hydantoins
ZA832679B (en) * 1982-05-07 1983-12-28 Ici Plc Indoline derivatives
US4430337A (en) 1982-06-23 1984-02-07 Pfizer Inc. Alicyclic substituted oxazolidine-2,4-diones having hypoglycemic activity
US4556670A (en) * 1982-12-06 1985-12-03 Pfizer Inc. Spiro-3-hetero-azolones for treatment of diabetic complications
US4464380A (en) * 1983-05-25 1984-08-07 Pfizer Inc. Imidazolidinedione derivatives
US4533667A (en) * 1983-05-25 1985-08-06 Pfizer Inc. Imidazolidinedione derivatives
DK277484A (da) * 1983-06-23 1984-12-24 Hoffmann La Roche Thiazolidinderivater
JPS61200991A (ja) * 1985-03-04 1986-09-05 Sanwa Kagaku Kenkyusho:Kk スピロ―３―ヘテロアゾリジン化合物、その製法及びそれを有効成分とする糖尿病合併症の予防及び治療剤
DE3522791C1 (en) * 1985-06-26 1987-01-02 Ferroplast Gmbh Positioning wall for lagging a cavity to be filled with a hardenable material in mining or tunnelling
US4853410A (en) * 1986-01-17 1989-08-01 Pfizer Inc. Hydroxyacetic acid derivatives for the treatment of diabetic complications
US5039672A (en) * 1990-04-05 1991-08-13 Pfizer Inc. Heterocyclic compounds as aldose reductase inhibitors
US5068332A (en) * 1990-10-12 1991-11-26 American Home Products Corporation Alkylidene analogs of 1'-aminospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones useful as aldose reductase inhibitors
US5102886A (en) * 1990-10-12 1992-04-07 American Home Products Corporation 1'-aminospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones and analogs thereof useful as aldose reductase inhibitors
FR2707981B1 (fr) * 1993-07-20 1995-09-01 Adir Nouveaux dérivés de benzospiroalcène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
CA2376919C (en) 1999-06-18 2008-11-04 Merck & Co., Inc. Arylthiazolidinedione and aryloxazolidinedione derivatives
WO2000078313A1 (en) 1999-06-18 2000-12-28 Merck & Co., Inc. Arylthiazolidinedione and aryloxazolidinedione derivatives
ITPI20060083A1 (it) * 2006-07-11 2008-01-12 Univ Pisa Derivati 2,2-dimetilcromanici 4-spiro-eterocicilici azotati (a 5 e 6 termini) n-sostituiti quali cardio-protettori nei confronti dell'insulto ischemico
USD775790S1 (en) * 2015-11-18 2017-01-10 Ginger Damon Motorcycle jacket
JP2021507767A (ja) 2017-12-21 2021-02-25 エシティ・ハイジーン・アンド・ヘルス・アクチエボラグ 吸収性物品及び吸収性物品を製造する方法
JP7150023B2 (ja) 2017-12-21 2022-10-07 エシティ・ハイジーン・アンド・ヘルス・アクチエボラグ 吸収性物品

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1204232B (de) * 1959-07-16 1965-11-04 Ncr Co Verfahren zur Herstellung von Derivaten von 3-Alkyl-3'-methyl-spiro[benzoxazolin-2, 2'-(2'H-1'-benzopyran)]
US3532744A (en) * 1967-07-28 1970-10-06 American Home Prod 1- and 2-amino substituted indane and tetralene carboxylic acids
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
CA1088945A (en) * 1976-10-18 1980-11-04 Pfizer Limited Hydantoin derivatives as therapeutic agents

Also Published As

Publication number Publication date
LU81613A1 (fr) 1980-04-21
DD146602A5 (de) 1981-02-18
YU41488B (en) 1987-08-31
NL7906318A (nl) 1980-02-25
PT70086A (en) 1979-09-01
IN152416B (zh) 1984-01-07
AU535170B2 (en) 1984-03-08
EG14639A (en) 1985-03-31
CS208129B2 (en) 1981-08-31
AT366689B (de) 1982-04-26
GB2033904A (en) 1980-05-29
YU199979A (en) 1983-06-30
FI65255B (fi) 1983-12-30
FR2440950B1 (zh) 1981-06-12
ZA794379B (en) 1980-08-27
US4200642A (en) 1980-04-29
IL58076A0 (en) 1979-12-30
FR2440949A1 (fr) 1980-06-06
JPS55129279A (en) 1980-10-06
IT1123536B (it) 1986-04-30
DK258479A (da) 1980-02-22
SU942597A3 (ru) 1982-07-07
HU179746B (en) 1982-12-28
GB2028318B (en) 1982-08-04
AR225614A1 (es) 1982-04-15
IE48932B1 (en) 1985-06-26
IT7925182A0 (it) 1979-08-20
JPS5943954B2 (ja) 1984-10-25
NO792699L (no) 1980-02-22
FR2442851B1 (zh) 1983-06-17
NZ191350A (en) 1984-04-27
IE791592L (en) 1980-02-21
CH639974A5 (fr) 1983-12-15
PL130686B1 (en) 1984-08-31
GB2028318A (en) 1980-03-05
DE2953954C2 (zh) 1987-12-03
CA1121361A (en) 1982-04-06
SE447116B (sv) 1986-10-27
ATA560579A (de) 1981-09-15
FR2440950A1 (fr) 1980-06-06
JPS55129280A (en) 1980-10-06
DE2933441C2 (de) 1987-04-23
FI65255C (fi) 1984-04-10
JPS55129288A (en) 1980-10-06
FI792567A (fi) 1980-02-22
FR2440949B1 (zh) 1981-06-12
ES483511A1 (es) 1980-09-01
FR2442851A1 (fr) 1980-06-27
IL58076A (en) 1982-07-30
GR71913B (zh) 1983-08-16
PL217881A1 (zh) 1981-01-02
SE7906949L (sv) 1980-02-22
GB2033904B (en) 1982-08-04
JPS6011915B2 (ja) 1985-03-28
JPS5528996A (en) 1980-02-29
AU5009279A (en) 1980-02-28
BE878311A (fr) 1980-02-20
JPS6011914B2 (ja) 1985-03-28
DE2933441A1 (de) 1980-02-28
DE2953954A1 (zh) 1982-09-02
JPS5946517B2 (ja) 1984-11-13

Similar Documents

Publication Publication Date Title
PH15877A (en) Novel n-heterocyclyl-4-piperidiamines,pharmaceutical composition containing same and method of use
PH18091A (en) Novel spiro-oxazolidindiones,pharmaceutical compositions containing same and method of use thereof
NZ192476A (en) Substituted benzamides and pharmaceutical compositions containing them
PH17552A (en) Novel chloro-and alkoxy-substituted-2,4-diaminoquinazolines,their pharmaceutical compositions and method of use
IL56411A0 (en) New derivatives of 4-amino-5-alkylsulphonyl-ortho-anisamides, their preparation and pharmaceutical compositions containing them
PH14287A (en) Naphthyridine derivatives,pharmaceutical compositions containing same and method of treatment thereof
IL58123A (en) 4,5-diaryl-2-nitroimidazoles,their preparation and pharmaceutical compositions containing them
JPS54135776A (en) Pharmaceutical composition and method
IL56407A (en) 4-amino-3-sulfamoylpyridyl derivatives and pharmaceutical compositions containing them
PH19005A (en) Penicillanic acid derivatives,pharmaceutical compositions containing the same and method of use thereof
DE2965287D1 (en) Bis-imidazoles, their preparation and pharmaceutical compositions containing them
IL57268A0 (en) Di-o-n-alkyl clycerol derivatives and pharmaceutical compositions containing them
IL58415A0 (en) Phenyl-quinolizidines their manufacture and pharmaceutical compositions containing them
PH14398A (en) Pharmaceutical compounds,compositions containing same and method of use
GB2044756B (en) Fluoro-amines processes for their preparation and pharmaceutical compositions containing them
GB2038802B (en) Aryltrifluoroethanols process for their preparation and pharmaceutical compositions containing them
IL57476A0 (en) Compounds of the muramy-peptide type and pharmaceutical compositions containing them
IL57891A0 (en) Alkylthiophenoxyalkylamines,their preparation and pharmaceutical compositions containing them
DE2966444D1 (en) Benzopyranotriazoles, preparation of these compounds and pharmaceutical composition containing them
DE2960503D1 (en) Novel androstadienes, processes for their preparation and pharmaceutical compositions containing them
PH17057A (en) Kijanimicin and salts thereof,pharmaceutical compositions containing same and process of preparring same
PH16860A (en) Novel indane derivatives,pharmaceutical compositions containing said derivatives and method of use thereof
IL57882A (en) 2-thiophenecarboxamido-alkyl-mercaptans and pharmaceutical compositions containing them
HK12384A (en) Novel veratramides,their preparation and pharmaceutical compositions containing them
IL56613A0 (en) Carboxylates of 3-oxo-androst adienes,their preparation and pharmaceutical compositions containing same

Legal Events

Date Code Title Description
AT Record of annual fee paiements

Year of fee payment: 14